Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr.

Phytomedicine

Volumn 14, Issue 7-8, 2007, Pages 546-550

  Wirasathien, L ^a   Pengsuparp, T ^a   Suttisri, R ^a   Ueda, H ^b   Moriyasu, M ^b   Kawanishi, K ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Aldose reductase; Diabetes; Dihydroflavonol glycosides; Stelechocarpus cauliflorus

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ENGELETIN; FLAVONOID GLYCOSIDE; STELECHOCARPUS CAULIFLORUS EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; ENZYME INHIBITION; IC 50; MEDICINAL PLANT; PLANT LEAF; PRIORITY JOURNAL; STELECHOCARPUS CAULIFLORUS;

ALDEHYDE REDUCTASE; ANNONACEAE; FLAVONOLS; GLYCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; MOLECULAR STRUCTURE; PLANT EXTRACTS; PLANT LEAVES;

ANNONACEAE; STELECHOCARPUS CAULIFLORUS;

EID: 34447512444     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.09.001     Document Type: Article

References (20)

1. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67 (2005) 3-21
2. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 21 (2003) 3-12
3. 1H-NMR spectroscopy. Chem. Pharm. Bull. 43 (1995) 338-339
4. de la Fuente J.A., and Manzanaro S. Aldose reductase inhibitors from natural sources. Nat. Prod. Rep. 20 (2003) 243-251
5. Gaffield W., and Waiss Jr. A.C. Structural relationships and interconversions of isomeric astilbins. J. Org. Chem. 40 (1975) 1057-1061
6. Haraguchi H., Mochida Y., Sakai S., Masuda H., Tamura Y., Mizutani K., Tanaka O., and Chou W.H. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis. Biosci. Biotechnol. Biochem. 60 (1996) 945-948
7. Haraguchi H., Ohmi I., Masuda H., Tamura Y., Mizutani K., Tanaka O., and Chou W.-H. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia 52 (1996) 564-567
8. Haraguchi H., Ohmi I., Fukuda A., Tamura Y., Mizutani K., Tanaka O., and Chou W.-H. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci. Biotechnol. Biochem. 61 (1997) 651-654
9. Kador P.F., Kinoshita J.H., and Sharpless N.E. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J. Med. Chem. 28 (1985) 841-849
10. Matsuura N., Aradate T., Sasaki C., Kojima H., Ohara M., Hasegawa J., and Ubukata M. Screening system for the Maillard reaction inhibitor from natural product extracts. J. Health Sci. 48 (2002) 520-526
11. Morimitsu Y., Yoshida K., Esaki S., and Hirota A. Protein glycation inhibitors from thyme (Thymus vulgaris). Biosci. Biotechnol. Biochem. 59 (1995) 2018-2021
12. Nagasawa T., Tabata N., Ito Y., Nishizawa N., Aiba Y., and Kitts D.D. Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol. Cell Biochem. 249 (2003) 3-10
13. Nishimura C., Yamaoka T., Mizutani M., Yamashita K., Akera T., and Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim. Biophys. Acta 1078 (1991) 171-178
14. Okuda J., Miwa I., Inagaki K., Horie T., and Nakayama M. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Biochem. Pharmacol. 31 (1982) 3807-3822
15. Silva D.H.S., Yoshida M., and Kato M.J. Flavonoids from Iryanthera sagotiana. Phytochemistry 46 (1997) 579-582
16. Thomas M.C., Baynes J.W., Thorpe S.R., and Cooper M.E. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets 6 (2005) 453-474
17. Varma S.D., and Kinoshita J.H. Inhibition of lens aldose reductase by flavonoids - their possible role in the prevention of diabetic cataracts. Biochem. Pharmacol. 25 (1976) 2505-2513
18. Wada R., and Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann. N.Y. Acad. Sci. 1043 (2005) 598-604
19. Wautier J.L., and Guillausseau P.J. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 27 (2001) 535-542
20. Yamagishi S., and Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 11 (2005) 2279-2299